Rigil Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.40 M
as on 06-07-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.25 Cr
as on 06-07-2024
- Satisfied Charges ₹ 2.17 Cr
as on 06-07-2024
- Revenue 9.27%
(FY 2023)
- Profit 22.44%
(FY 2023)
- Ebitda -28.64%
(FY 2023)
- Net Worth 12.80%
(FY 2023)
- Total Assets -4.66%
(FY 2023)
About Rigil Biotech
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹4.25 Cr. The company has closed loans amounting to ₹2.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shivendra Srivastava and Gaurav Agarwal serve as directors at the Company.
- CIN/LLPIN
U24239DL2004PTC127280
- Company No.
127280
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rigil Biotech Private Limited offer?
Rigil Biotech Private Limited offers a wide range of products and services, including Tea & Coffee, Coffee Powder, Milk & Dairy Products, Flavoured Milk, Dairy Products, Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine, Flavors Aromatics, Aspartame, Wpurif.
Who are the key members and board of directors at Rigil Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivendra Srivastava  | Managing Director | 30-Jun-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurav Agarwal | Director | 30-Jun-2004 | Current |
Financial Performance and Corporate Structure Insights of Rigil Biotech.
Rigil Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.27% increase. The company also saw a substantial improvement in profitability, with a 22.44% increase in profit. The company's net worth Soared by an impressive increase of 12.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rigil Biotech?
In 2023, Rigil Biotech had a promoter holding of 74.95% and a public holding of 25.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Venelec Electromech Industries Private LimitedActive 36 years 6 monthsShivendra Srivastava and Gaurav Agarwal are mutual person
Rigil Techno India Private LimitedActive 24 years 7 monthsShivendra Srivastava and Gaurav Agarwal are mutual person
_PRIVATE_LIMITED.webp)
Hongshang (India) Private LimitedActive 12 years 11 monthsShivendra Srivastava and Gaurav Agarwal are mutual person
Quality Products Lab Private LimitedActive 12 years 3 monthsShivendra Srivastava and Gaurav Agarwal are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Dec 2023 | ₹4.25 Cr | Open |
Others Creation Date: 19 Sep 2016 | ₹1.60 Cr | Satisfied |
Hdb Financial Services Limited Creation Date: 31 Aug 2015 | ₹5.70 M | Satisfied |
How Many Employees Work at Rigil Biotech?
Unlock and access historical data on people associated with Rigil Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rigil Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rigil Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
